Plerixafor is effective given either preemptively or as a rescue strategy in poor stem cell mobilizing patients with multiple myeloma

Publisher: John Wiley & Sons Inc

E-ISSN: 1537-2995|55|2|275-283

ISSN: 0041-1132

Source: TRANSFUSION, Vol.55, Iss.2, 2015-02, pp. : 275-283

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract